Company & Sponsor Intelligence

Otsuka Pharmaceutical Development & Commercialization, Inc.

Evidence-linked intelligence derived from the current NeuroRisk clinical research corpus. Coverage reflects indexed source data and is not a claim of complete company activity.

Request enterprise analysis →

Indexed trials13

Recruiting1

Completed12

Countries1

Therapeutic footprint

adhdalzheimersautismbipolar_disordereating_disordersepilepsyschizophrenia

Indexed studies

NCT04241965A Single-blind, Placebo-controlled, Outpatient Trial to Assess the Effects of Single Oral Tablet Dose of OPC-214870
epilepsy · United StatesPHASE1

NCT01423916Trial to Evaluate the Effects of OPC-34712 on QT/QTc in Subjects With Schizophrenia or Schizoaffective Disorder
schizophrenia · United StatesPHASE1

NCT02144415A Study to Evaluate the Abuse Potential of EB-1020 Immediate-Release in Healthy Recreational Stimulant Users
adhd · United StatesPHASE1

NCT01862640A Phase 3, 12-week, Multicenter, Randomized, Double-blind, Placebo-controlled Trial to Evaluate the Efficacy, Safety, and Tolerability of 2 Fixed Doses of Brexpiprazole in the Treatment of Alzheimer's Agitation
alzheimers · United StatesPHASE3

NCT00365859Study of Aripiprazole in the Treatment of Serious Behavioral Problems in Children and Adolescents With Autistic Disorder (AD)
autism · United StatesPHASE3

NCT01939353Study of Flexible Doses of the Triple Reuptake Inhibitor EB-1020 Sustained Release (SR) in the Treatment of Adult Males With Attention-Deficit Hyperactivity Disorder
adhd · United StatesPHASE2

NCT04369391A Clinical Study to Investigate the Effect of an Investigational Drug on Electrocardiogram Intervals in Adults With Schizophrenia.
schizophrenia · United StatesPHASE1

NCT07759154A Study to Test the Effects of Centanafadine in Adults With Attention-deficit/Hyperactivity Disorder and Emotional Dysregulation
adhd · United StatesPHASE3

NCT00261443A Study of Aripiprazole (Abilify) in Patients With Bipolar Mania
bipolar_disorder · United StatesPHASE4

NCT05113953A Trial of Centanafadine Efficacy, Safety, and Tolerability in Adult Subjects With Binge Eating Disorder
eating_disorders · United StatesPHASE2

NCT00110461Aripiprazole in Children and Adolescents With Bipolar I Disorder
bipolar_disorder · United StatesPHASE3

NCT06973577P3b Short-term Study of CTN in Patients With ADHD and Comorbid Anxiety
adhd · United StatesPHASE3

Intelligence layer updated: 2026-10-14 06:11:28.884102+00:00

Enterprise intelligence

Compare sponsor activity, recruiting momentum, therapeutic exposure, geography and connected research signals across the neuroscience ecosystem.

Request comparative intelligence →